₹81.00
+3.85%NSE close, 16 Nov 2026
−8.26%
Banka BioLoo is a small cap company, listed on NSE under the symbol BANKA. At ₹81.00 a share, the market values the whole company at ₹89 crore.
In FY26, it reported sales of ₹57 crore and a net profit of ₹0 crore, an operating margin of 9.1%. Over the last three years, sales grew 10.5% a year and net profit fell 48.3% a year.
The market values the company at 57.1 times its profit over the last twelve months and 2.06 times its book value; its return on equity is 3.6% and its borrowings are 1.02 times its equity.
Promoters hold 52.02% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 5.1%, and it is 16.1% below its 52-week high.
₹ crore. Consolidated figures.
ESOP Trading approval for 5000 equity shares
Unaudited financial results for the quarter and half year ended 30 September 2026.
Financial results for the quarter and half year ended 30 September 2026
| Dec 2025 |
|---|
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 14.0 | 16.3 | 12.9 | 12.4 | 14.0 | 14.8 | 11.1 | 13.0 | 15.3 | 17.7 | 10.6 | 11.8 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 12.2 | 15.2 | 11.1 | 16.9 | 14.0 | 15.0 | 10.8 | 13.0 | 13.8 | 14.3 | 8.7 | 9.5 |
| Operating profit | 1.8 | 1.1 | 1.8 | −4.5 | 0.0 | −0.2 | 0.3 | −0.0 | 1.5 | 3.4 | 1.8 | 2.3 |
| Operating margin | 12.8% | 6.6% | 13.6% | -36.1% | 0.2% | -1.1% | 3.1% | -0.1% | 9.6% | 19.1% | 17.3% | 19.4% |
| Other income | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 1.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Interest | 0.7 | 0.6 | 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.2 | 1.2 |
| Depreciation | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | 0.8 | 0.7 | 0.9 | 1.0 |
| Profit before tax | 0.7 | −0.1 | 0.4 | −6.2 | −1.5 | −1.8 | −0.1 | −1.6 | −0.2 | 1.6 | −0.1 | 0.2 |
| Tax | −0.0 | 0.2 | 0.1 | −0.1 | −0.0 | −0.2 | −0.1 | −0.5 | −0.0 | −0.0 | −0.1 | 0.1 |
| Net profit | 0.7 | – | 0.3 | −6.1 | −1.5 | −1.6 | 0.0 | −1.1 | −0.2 | 1.6 | −0.0 | 0.1 |
| EPS (₹) | 0.65 | – | 0.27 | -5.65 | -1.34 | -1.50 | 0.00 | -1.00 | -0.14 | 1.45 | -0.01 | 0.12 |
₹ crore, financial years to March.
| Line | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Sales | 30.5 | 38.8 | 42.4 | 50.0 | 54.2 | 57.1 |
| Expenses | 27.1 | 33.2 | 36.4 | 46.4 | 57.0 | 51.9 |
| Operating profit | 3.4 | 5.5 | 5.9 | 3.6 | −2.9 | 5.2 |
| Operating margin | 11.2% | 14.2% | 14.0% | 7.2% | -5.3% | 9.1% |
| Other income | 0.6 | 0.5 | 0.7 | 0.5 | 0.3 | 1.3 |
| Interest | 1.5 | 1.7 | 1.6 | 2.5 | 3.8 | 3.7 |
| Depreciation | 0.6 | 0.9 | 1.5 | 2.2 | 2.5 | 2.8 |
| Profit before tax | 1.9 | 3.3 | 3.6 | −0.5 | −9.2 | −0.3 |
| Tax | −0.3 | 0.2 | 1.1 | 0.1 | −0.2 | −0.7 |
| Net profit | 2.2 | 3.1 | 2.5 | −0.5 | −8.9 | 0.4 |
| EPS (₹) | 2.15 | 3.02 | 2.40 | -0.16 | -8.21 | 0.32 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −0.4 | 0.9 | 1.1 | 3.3 |
| From investing | −2.7 | −6.0 | −2.2 | −11.7 |
| From financing | 1.0 | 5.1 | 11.1 | 7.2 |
| Spent on fixed assets | −3.2 | −4.5 | −6.0 | −11.8 |
| Free cash flow | −3.6 | −3.6 | −5.0 | −8.5 |
Margins, returns, debt, tax and cash.
| Line | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Net margin | 7.2% | 8.0% | 6.0% | -1.0% | -16.4% | 0.6% |
| Operating margin | 11.2% | 14.2% | 14.0% | 7.2% | -5.3% | 9.1% |
| Return on equity | – | – | 6.3% | -1.2% | -28.3% | 0.9% |
| Return on capital employed | – | – | 9.4% | 3.0% | -8.2% | 4.3% |
| Return on assets | – | – | 3.9% | -0.6% | -10.9% | 0.4% |
| Debt to equity | – | – | 0.37 | 0.62 | 1.09 | 0.99 |
| Interest coverage | 2.20 | 2.90 | 3.30 | 0.80 | -1.40 | 0.90 |
| Debt to assets | – | – | 0.23 | 0.32 | 0.42 | 0.39 |
| Current ratio | – | – | 2.24 | 1.95 | 1.41 | 1.58 |
| Quick ratio | – | – | 1.77 | 1.62 | 1.25 | 1.44 |
| Cash ratio | – | – | 0.05 | 0.01 | 0.01 | 0.24 |
| Asset turnover | – | – | 0.65 | 0.65 | 0.66 | 0.57 |
| Fixed asset turnover | – | – | 4.81 | 3.56 | 3.52 | 2.18 |
| Inventory turnover | – | – | – | 2.00 | 2.70 | 2.30 |
| Receivables turnover | – | – | 3.60 | 2.20 | 1.90 | 2.00 |
| Gross margin | – | – | – | 67.5% | 70.5% | 75.4% |
| Cash from operations to profit | – | -14.0% | – | – | – | 300.0% |
| Effective tax rate | – | 6.1% | 29.8% | – | – | – |
The financial results for the period ended September 30, 2026.
Significant movement in price has been observed in Banka BioLoo Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the…
Significant movement in price has been observed in Banka BioLoo Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the…
Allotment of 5000 Shares.
Grant of 2000 Options.
Grant of 5000 Options.
A copy Srutinizers report of Annual General Meeting held on September 17, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 17, 2026
Notice of Annual General Meeting to be held on September 17, 2026
The Book Closure, cut-off date and the remote e-voting timelines for 14th Annual General Meeting of the Company.